Skip to main content

COVID-19 vaccine developer takes key step toward coronavirus trial in early summer

The company's stock was up 38% in early trading Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.